EP3840837
Argínasa-hindrar og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.8.2019EP published:
20.3.2024EP application number:
19758683.7
EP translation filed:
29.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
20.8.2039Expiry date:
20.8.2026Next due date:
31.8.2026
Title in English:
ARGINASE INHIBITORS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
21.8.2019EP application
20.3.2024EP Publication
29.5.2024Translation submitted
15.6.2024Registration published
20.8.2026Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
WU, DedongAddress:
Waltham, MA 02451, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862721113 PDate:
22.8.2018Country:
US
Classification
Categories:
C07F 5/02, A61K 31/69, A61K 33/22, A61P 29/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.8.2024
Expires: 20.8.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.8.2025
Expires: 20.8.2026
Payer: Árnason Faktor ehf.